Nijkamp FP - Search Results

1

Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses.

Redegeld FA, van der Heijden MW, Kool M, Heijdra BM, Garssen J, Kraneveld AD, Van Loveren H, Roholl P, Saito T, Verbeek JS, Claassens J, Koster AS, Nijkamp FP. Redegeld FA, et al. Among authors: nijkamp fp. Nat Med. 2002 Jul;8(7):694-701. doi: 10.1038/nm722. Epub 2002 Jun 17. Nat Med. 2002. PMID: 12068287

2

Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?

Redegeld FA, Nijkamp FP. Redegeld FA, et al. Among authors: nijkamp fp. Trends Immunol. 2003 Apr;24(4):181-5. doi: 10.1016/s1471-4906(03)00059-0. Trends Immunol. 2003. PMID: 12697449

3

Elicitation of allergic asthma by immunoglobulin free light chains.

Kraneveld AD, Kool M, van Houwelingen AH, Roholl P, Solomon A, Postma DS, Nijkamp FP, Redegeld FA. Kraneveld AD, et al. Among authors: nijkamp fp. Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1578-83. doi: 10.1073/pnas.0406808102. Epub 2005 Jan 14. Proc Natl Acad Sci U S A. 2005. PMID: 15653775 Free PMC article.

4

Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction.

Rijnierse A, Koster AS, Nijkamp FP, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. J Immunol. 2006 Apr 1;176(7):4375-84. doi: 10.4049/jimmunol.176.7.4375. J Immunol. 2006. PMID: 16547276

5

Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseases.

Thio M, Blokhuis BR, Nijkamp FP, Redegeld FA. Thio M, et al. Among authors: nijkamp fp. Trends Pharmacol Sci. 2008 Apr;29(4):170-4. doi: 10.1016/j.tips.2008.01.004. Epub 2008 Mar 18. Trends Pharmacol Sci. 2008. PMID: 18353446 Review.

6

Immunoglobulin-free light chains mediate antigen-specific responses of murine dorsal root ganglion neurons.

Rijnierse A, Kroese AB, Redegeld FA, Blokhuis BR, van der Heijden MW, Koster AS, Timmermans JP, Nijkamp FP, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. J Neuroimmunol. 2009 Mar 31;208(1-2):80-6. doi: 10.1016/j.jneuroim.2009.01.008. Epub 2009 Feb 15. J Neuroimmunol. 2009. PMID: 19232443

7

Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases.

Rijnierse A, Redegeld FA, Blokhuis BR, Van der Heijden MW, Te Velde AA, Pronk I, Hommes DW, Nijkamp FP, Koster AS, Kraneveld AD. Rijnierse A, et al. Among authors: nijkamp fp. J Immunol. 2010 Jul 1;185(1):653-9. doi: 10.4049/jimmunol.0901129. Epub 2010 May 26. J Immunol. 2010. PMID: 20505143 Free article.

8

Antigen binding characteristics of immunoglobulin free light chains: crosslinking by antigen is essential to induce allergic inflammation.

Thio M, Groot Kormelink T, Fischer MJ, Blokhuis BR, Nijkamp FP, Redegeld FA. Thio M, et al. Among authors: nijkamp fp. PLoS One. 2012;7(7):e40986. doi: 10.1371/journal.pone.0040986. Epub 2012 Jul 20. PLoS One. 2012. PMID: 22911727 Free PMC article.

9

Functional role for Ig free light chains in immediate and delayed hypersensitivity responses.

Redegeld FA, Van Der Heijden MW, Kool M, Kraneveld AD, Nijkamp FP. Redegeld FA, et al. Among authors: nijkamp fp. Inflamm Res. 2004 Mar;53 Suppl 1:S6-8. doi: 10.1007/s00011-003-0302-9. Epub 2004 Mar 5. Inflamm Res. 2004. PMID: 15054593 Review. No abstract available.

10

Topical application of F991, an immunoglobulin free light chain antagonist, prevents development of contact sensitivity in mice.

van Houwelingen AH, Kaczynska K, Kraneveld AD, Kool M, Nijkamp FP, Redegeld FA. van Houwelingen AH, et al. Among authors: nijkamp fp. Clin Exp Allergy. 2007 Feb;37(2):270-5. doi: 10.1111/j.1365-2222.2007.02655.x. Clin Exp Allergy. 2007. PMID: 17250700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page